Cargando…

Treatment and resource utilization for menopausal symptoms in the United States: a retrospective review of real-world evidence from US electronic health records

OBJECTIVE: The aim of this study was to generate real-world evidence documenting use of prescription and nonprescription therapies recorded by health care providers for women experiencing vasomotor symptoms (VMS) associated with menopause. METHODS: This noninterventional, retrospective, observationa...

Descripción completa

Detalles Bibliográficos
Autores principales:	DePree, Barbara, Houghton, Katherine, Shiozawa, Aki, Esterberg, Elizabeth, King, Deanna D., Kim, Janet, Mancuso, Shayna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812413/ https://www.ncbi.nlm.nih.gov/pubmed/36576444 http://dx.doi.org/10.1097/GME.0000000000002095

Ejemplares similares

Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey
por: DePree, Barbara, et al.
Publicado: (2023)

Association between vasomotor symptom frequency and weight gain in the Study of Women's Health Across the Nation
por: Gibson, Carolyn J., et al.
Publicado: (2023)

Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis
por: Sharman Moser, Sarah, et al.
Publicado: (2020)

Real-World Health Care Resource Utilization and Costs Among US Patients with Knee Osteoarthritis Compared with Controls
por: Bedenbaugh, Angela V, et al.
Publicado: (2021)

A Real-World Study of Switching From Allopurinol to Febuxostat in a Health Plan Database
por: Altan, Aylin, et al.
Publicado: (2015)

Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
por: Studer, Sean, et al.
Publicado: (2018)

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population
por: Cheng, Wendy Y., et al.
Publicado: (2021)

A Real-World Assessment of Outcomes, Health Resource Utilization, and Costs Associated with Cerebral Edema in US Patients with Large Hemispheric Infarction
por: Tsao, Nicole, et al.
Publicado: (2021)

Increased Healthcare Resource Utilization and Direct and Indirect Costs in Patients with Depression and Comorbid Overactive Bladder: Evidence From a Retrospective, Matched Case–Control Cohort Analysis
por: Shiozawa, Aki, et al.
Publicado: (2020)

Real-world impact of fremanezumab on migraine symptoms and resource utilization in the United States
por: McAllister, Peter, et al.
Publicado: (2021)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France
por: Lin, Huamao Mark, et al.
Publicado: (2019)

Real-world utilization patterns and outcomes of colesevelam hcl in the ge electronic medical record
por: Hansen, Richard A, et al.
Publicado: (2013)

From real-world electronic health record data to real-world results using artificial intelligence
por: Knevel, Rachel, et al.
Publicado: (2023)

P924: TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A REAL-WORLD OBSERVATIONAL CHART REVIEW STUDY
por: Goyal, Ravi K, et al.
Publicado: (2023)

Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
por: Singh, Jasvinder A, et al.
Publicado: (2015)

US Health Resource Utilization and Cost Burden Associated with Choroideremia
por: Dong, Shaobin, et al.
Publicado: (2021)

Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
por: Singh, Jasvinder A., et al.
Publicado: (2015)

Patient Characteristics and Healthcare Resource Utilization Among Patients with COPD New to LAMA/LABA Fixed-Dose Combination Treatment in US-Based Real-World Practice
por: Ding, Bo, et al.
Publicado: (2020)

PB2359: HEALTHCARE RESOURCE UTILIZATION OF ADULT PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A REAL WORLD STUDY USING US VETERANS HEALTH ADMINISTRATION DATA
por: Zagadailov, E., et al.
Publicado: (2022)

Real-world effectiveness of osteoporosis therapies for fracture reduction in post-menopausal women
por: Yusuf, Akeem A., et al.
Publicado: (2018)

P1695: REAL-WORLD SURVIVAL, HEALTHCARE RESOURCE UTILIZATION, AND COSTS AMONG U.S. ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-GEMOX IN THE RELAPSED/REFRACTORY SETTING
por: Garg, Mahek, et al.
Publicado: (2023)

Understanding Attitudes, Beliefs, and Behaviors Surrounding Menopause Transition: Results from Three Surveys
por: Richard-Davis, Gloria, et al.
Publicado: (2022)

Persistent Organic Pollutants and Early Menopause in U.S. Women
por: Grindler, Natalia M., et al.
Publicado: (2015)

Can precision medicine get us through menopause?
por: Vieira-Potter, Victoria J.
Publicado: (2022)

Healthcare Resource Utilization in Patients Receiving Omalizumab for Allergic Asthma in a Real-World Setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2014)

The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity
por: McCann, William, et al.
Publicado: (2021)

Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy
por: Moccia, Marcello, et al.
Publicado: (2022)

P1059: REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN MYELOFIBROSIS PATIENTS WITH ANEMIA
por: Mascarenhas, John, et al.
Publicado: (2023)

Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis
por: Armstrong, April W., et al.
Publicado: (2019)

Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers
por: Faust, Elizabeth, et al.
Publicado: (2021)

Impact of sleep disturbances on employment and work productivity among midlife women in the US SWAN database: a brief report
por: Kagan, Risa, et al.
Publicado: (2021)

Healthcare Resource Utilization of Patients With COVID-19 Visiting US Hospitals
por: Moon, Rena C., et al.
Publicado: (2022)

1427. Healthcare Resource Utilization During Hospitalizations with UTI in the US, 2018
por: Zilberberg, Marya, et al.
Publicado: (2021)

Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
por: Senna, Maryanne, et al.
Publicado: (2021)

Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization
por: Hubert, Dominique, et al.
Publicado: (2021)

Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy
por: Colombo, Giorgio Lorenzo, et al.
Publicado: (2021)

Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA
por: Laliberté, François, et al.
Publicado: (2020)

Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset
por: Recht, Michael, et al.
Publicado: (2022)

Real-World Evidence of Aripiprazole Tablets with Sensor: Treatment Patterns and Impacts on Psychiatric Healthcare Resource Utilization
por: Hadzi Boskovic, Dusica, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ktf2eajm12oufe19k58n6h6ii